@article{3182171,
    title = "Long-Term Efficacy and Safety from the Copanlisib CHRONOS-1 Study in
Patients with Relapsed or Refractory Indolent B-Cell Lymphoma",
    author = "Dreyling, Martin and Santoro, Armando and Mollica, Luigina and Leppa, and Sirpa and Follows, George A. and Lenz, Georg and Kim, Won Seog and and Nagler, Arnon and Panayiotidis, Panayiotis and Demeter, Judit and Ozcan, and Muhit and Kosinova, Marina and Bouabdallah, Krimo and Morschhauser, and Franck and Stevens, Don and Trevarthen, David and Rodrigues, Liana and and Hiemeyer, Florian and Wang, MingLu and Garcia-Vargas, Jose and Childs, and Barrett H. and Zinzani, Pier Luigi",
    journal = "Blood advances",
    year = "2018",
    volume = "132",
    number = "1",
    publisher = "AMER SOC HEMATOLOGY",
    doi = "10.1182/blood-2018-99-114842"
}